Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · June 16, 2024

Risk of Hepatitis B Virus Reactivation in Patients With Psoriasis Treated With Biologics

Archives of Dermatological Research


Additional Info

Archives of Dermatological Research
Evaluation of risk for hepatitis B virus reactivation in patients with psoriasis treated with biologic therapies: a single-center retrospective study
Arch Dermatol Res 2024 May 11;316(5)163, GH Tabak, N Akdoğan, SD Günaydın, YE Parlar, HY Balaban, H Şimşek

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading